The BP - Personal Access

Online access for individual users includes access to the BP publication, in-year updates, and optional access to the BAN and BP archive. Single-user licences are granted solely to one designated holder of the product, and are restricted to use on two designated devices. When you purchase a BP single-user licence you will be emailed claim tokens which you may claim under your account, or pass to the intended user to claim.

You can find out more about the BP publication and what it contains on our designated About the BP page


The BP 2025 Online

Available 1 August 2024 | Effective 1 January 2025 | Superseding the BP 2024

What's new in BP 2025

The BP 2025 supersedes the BP 2024 and becomes legally effective on the 1 January 2025. This edition incorporates new monographs from both the BP and Ph.Eur. along with a significant number of revised monographs.

  • 14 new BP monographs, 32 new Ph. Eur. monographs. Including two new monographs on for Paracetamol Infusion and Paracetamol Oral Solution and a new monograph for Solifenacin Oral Suspension which is accompanied by additional information on the website. This information provides a case study demonstrating how users can scale monograph methods to reduce run times and solvent usage.
  • 105 amended BP monographs. 
  • All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 to 11.5. 
  • Ph. Eur. supplements 11.6 to 11.8 included as in-year online and download product updates. 
  • Updated references to new BPCRS included in the BP 2025 to ensure that you remain compliant. 

Online tools and guides: 

We have made several changes to the pharmacopoeia website to help improve your user experience.  

  • Webchat – Available Monday to Friday 8am to 6pm BST, you can now instantly reach a member of our customer service team should you have any queries regarding the BP publication or are experiencing technical difficulties.  
  • Print functionality on monographs – You can now directly print your favourite monographs on BP online. 
  • Provide website feedback more easily – You should now see a feedback button on all pages on the pharmacopoeia.com website. Making it easier to provide feedback on specific pages. 
  • Request proforma invoice – If you would like to self-serve on the pharmacopoeia.com website to purchase the BP publication, but would prefer not to pay via credit card, you can now request a proforma invoice. Simply submit all the necessary information and a customer service agent will be in touch within one working day. 

BP Online 2025 - £875

Personal access to the British Pharmacopoeia (BP) 2025 online for one named user. Access will expire on the 31 March 2026

QTY (Max 10)    

BP 2025 and BAN Online - £1,025

Personal access to the British Pharmacopoeia (BP) 2025 online for one named person. With this licence you will also receive access to the British Approved Names (BAN). Access will expire on the 31 March 2026.

QTY (Max 10)    

BP 2025 and BP Archive Online - £1,075

Personal access to the British Pharmacopoeia (BP) 2025 for one named Person. With this licence you will also receive access to the BP Archive which includes all editions since BP 2014. Access will expire on 31 March 2026.

QTY (Max 10)    

BP 2025, BP Archive and BAN Online - £1,225

Personal access to the British Pharmacopoeia (BP) 2025 online for one named person. With this licence you will also receive access to the BP Archive and British Approved Names (BAN). Our archive includes all editions since BP 2014. Access will expire on the 31 March 2026.

QTY (Max 10)    

The BP 2024 Online

Available 1 August 2023 | Effective 1 January 2024 | Superseding the BP 2023

What's new in BP 2024

The BP 2024 supersedes the BP 2023 and becomes legally effective on the 1 January 2024. This edition incorporates new monographs from both the BP and Ph.Eur. along with a significant number of revised monographs.

  • 27 new BP monographs, 17 new Ph. Eur. monographs.
  • 93 amended BP monographs.
  • All monographs from the Ph. Eur. 11th edition
  • Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates. 
  • We are updating the BP website to improve your experience of using the site. Updated features for the 2024 edition include: 
    • A fresh and user-friendly site design, coupled with improved navigation 
    • Enhanced purchasing journeys for seamless experience
    • Enhanced layout allows you to search and find the monographs you need
    • Advanced in-publication search functionality
    • A revamped timeline and tracked changes feature, enabling you to track the evolution of monographs over time

BP Online 2024 - £875

Personal access to the British Pharmacopoeia (BP) 2024 online for one named user. Access will expire on the 31st March 2025

QTY (Max 10)

BP 2024 and BP Archive Online - £1,075

Personal access to the British Pharmacopoeia (BP) 2024 for one named Person. With this licence you will also receive access to the BP Archive which includes all editions since BP 2014. Access will expire on 31st March 2025.

QTY (Max 10)

BP 2024 and BAN Online - £1,025

Personal access to the British Pharmacopoeia (BP) 2024 online for one named person. With this licence you will also receive access to the British Approved Names (BAN). Access will expire on the 31st March 2025.

QTY (Max 10)

BP 2024, BP Archive and BAN Online - £1,225

Personal access to the British Pharmacopoeia (BP) 2024 online for one named person. With this licence you will also receive access to the BP Archive and British Approved Names (BAN). Our archive includes all editions since BP 2014. Access will expire on the 31st March 2025.

QTY (Max 10)

If you have a question about buying the BP, for example, which format is right for you and pricing, contact BP publication sales enquiries.

e: pharmahealth@tso.co.uk
t: +44 (0) 333 0917 023
a: The Stationery Office Ltd (TSO), PO box 29, Norwich, NR3 1GN
Our sales team are available Monday to Friday: 8:00 to 18:00 GMT

Webchat Monday to Friday, 8:00 to 18:00 GMT

Alternatively, please browse our shop and make purchases using card payment or request a proforma or invoice for payment by bank transfer.